Sedana Medical AB (publ)

Kvartalsrapporter

Visar 1 grupper

  1. Kvartalsrapport Q1 2026

    ENSV
    →

    Financial Performance

    • Net sales for the quarter totaled MSEK 53.4 (57.5), a decrease of 7% reported (2% at constant exchange rates).
    • Group EBITDA reached MSEK 1.8 (-0.6), reflecting a margin of 3% (-1%).
    • Ex-US EBITDA margin was 10% (7%), or 11% at constant exchange rates.
    • Operating income (EBIT) was MSEK -5.7 (-5.9).
    • Net income for the period improved to MSEK…

    Öppna rapport